{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:40:16Z","timestamp":1780105216934,"version":"3.54.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T00:00:00Z","timestamp":1431043200000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.rgmx.2015.04.001","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T00:18:48Z","timestamp":1434500328000},"page":"150-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagn\u00f3stico y tratamiento de los s\u00edndromes de sobreposici\u00f3n de hepatitis autoinmune"],"prefix":"10.1016","volume":"80","author":[{"given":"O.","family":"Aguilar-N\u00e1jera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Velasco-Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2015.04.001_bib0270","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4103\/1319-3767.145316","article-title":"Overlap syndromes: An emerging diagnostic and therapeutic challenge","volume":"20","author":"Dhiman","year":"2014","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0275","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0280","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0285","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0290","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouill\u00e8res","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0295","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","article-title":"Genetics of liver disease: Immunogenetics and disease pathogenesis","volume":"53","author":"Donaldson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0300","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2036.2012.05223.x","article-title":"Review article: Overlap syndromes and autoimmune liver disease","volume":"36","author":"Trivedi","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1155\/2013\/198070","article-title":"Diagnosis and management of the overlap syndromes of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0310","series-title":"Atlas of liver pathology","author":"Chan","year":"2014"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0315","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0320","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: Management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0325","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","article-title":"Overlap syndromes among autoimmune liver diseases","volume":"14","author":"Rust","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0330","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/CRIAI:28:2:105","article-title":"Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis","volume":"28","author":"Schramm","year":"2005","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.rgmx.2015.04.001_bib0335","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cld.317","article-title":"Overlap syndrome: A real syndrome","volume":"3","author":"Haldar","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cld.2014.09.005","article-title":"Diagnosis and management of overlap syndromes","volume":"19","author":"Bunchorntavakul","year":"2015","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0345","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis\/autoimmune hepatitis overlap syndrome: Clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0350","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0355","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O\u2019Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0360","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/MCG.0b013e3181587d18","article-title":"Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis","volume":"42","author":"Montano-Loza","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0365","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cgh.2010.03.004","article-title":"Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome","volume":"8","author":"Kuiper","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0370","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0034-1383734","article-title":"Primary biliary cirrhosis: Overlaps with other autoimmune disorders","volume":"34","author":"Floreani","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0375","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/ajg.2009.126","article-title":"The serological profile of the autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome","volume":"104","author":"Muratori","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hep.1840200133","article-title":"The molecular genetics of autoimmune liver disease","volume":"20","author":"Donaldson","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0385","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1665-2681(19)31583-2","article-title":"Does HLA-DR7 differentiate the overlap syndrome of autoimmune hepatitis\/primary biliary cirrhosis (AIH-PBC) from those with autoimmune hepatitis type 1","volume":"10","author":"Coss-Adame","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0390","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/08820130902846282","article-title":"HLA-DR allele frequencies in mexican mestizos with autoimmune liver diseases including overlap syndromes","volume":"38","author":"Zepeda-Gomez","year":"2009","journal-title":"Immunol Invest"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0395","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0400","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/apt.12592","article-title":"Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis","volume":"39","author":"Czaja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0405","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/hepr.12210","article-title":"Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy","volume":"44","author":"Yoshioka","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0410","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: Long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0415","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3350\/cmh.2012.18.4.375","article-title":"Prognostic indicators in primary biliary cirrhosis: Significance of revised IAHG (International Autoimmune Hepatitis Group) score","volume":"18","author":"Jung","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0420","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","article-title":"Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid","volume":"35","author":"Joshi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0425","first-page":"326","article-title":"The overlap syndromes of autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0430","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00042737-200510000-00011","article-title":"Co-existence of primary biliary cirrhosis and primary sclerosisng colangitis: A rare overlap syndrome put in perspective","volume":"17","author":"Kingham","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0435","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.cgh.2013.08.039","article-title":"Cholestatic phenotypes of autoimmune hepatitis","volume":"12","author":"Czaja","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0440","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: Evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0445","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.23024","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: A prospective magnetic resonance imaging and histological study","volume":"50","author":"Lewin","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0450","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune heptitis overlap s\u00edndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0455","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0b013e318157c614","article-title":"Characteristics and long-term prognosis of the autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"43","author":"L\u00fcth","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0460","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jmri.22048","article-title":"Overlap syndrome of autoimmune chronic liver diseases: MRI findings","volume":"31","author":"Hyslop","year":"2010","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0465","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0470","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0475","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04727.x","article-title":"The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes","volume":"34","author":"Baven-Pronk","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0480","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genomewide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0485","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/jhep.2000.7878","article-title":"Autoimmune cholangitis within the spectrum of autoimmune liver disease","volume":"31","author":"Czaja","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0490","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejim.2008.06.004","article-title":"High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis","volume":"20","author":"Olsson","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0495","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0500","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cld.2012.12.006","article-title":"Cholestatic liver disease overlap syndromes","volume":"17","author":"Mayo","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0505","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cld.2012.11.007","article-title":"IgG4-associated cholangitis","volume":"17","author":"Silveira","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0510","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ajg.2011.375","article-title":"The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice","volume":"107","author":"Alswat","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0515","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0520","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cld.2013.07.015","article-title":"Drug-induced cholestasis","volume":"17","author":"Bhamidimarri","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0525","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/liv.12027","article-title":"Liver transplantation for overlap s\u00edndromes of autoimmune liver diseases","volume":"33","author":"Bhanji","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.rgmx.2015.04.001_bib0530","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1872-034X.2012.01018.x","article-title":"Living-donor liver transplantation for autoimmune hepatitis and autoimmune hepatitis-primary biliary cirrhosis overlap syndrome","volume":"42","author":"Yamashiki","year":"2012","journal-title":"Hepatol Res"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090615000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090615000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T03:17:53Z","timestamp":1566875873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090615000373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0375090615000373"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2015.04.001","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagn\u00f3stico y tratamiento de los s\u00edndromes de sobreposici\u00f3n de hepatitis autoinmune","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2015.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}